KAMADA LTD (KMDA) Stock Fundamental Analysis

NASDAQ:KMDA • IL0010941198

8.8 USD
-0.11 (-1.23%)
Last: Feb 27, 2026, 10:43 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

Taking everything into account, KMDA scores 6 out of 10 in our fundamental rating. KMDA was compared to 521 industry peers in the Biotechnology industry. While KMDA belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. KMDA may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make KMDA suitable for value investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • KMDA had positive earnings in the past year.
  • In the past year KMDA had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: KMDA reported negative net income in multiple years.
  • Of the past 5 years KMDA 4 years had a positive operating cash flow.
KMDA Yearly Net Income VS EBIT VS OCF VS FCFKMDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

  • KMDA's Return On Assets of 5.42% is amongst the best of the industry. KMDA outperforms 91.55% of its industry peers.
  • KMDA has a Return On Equity of 7.71%. This is amongst the best in the industry. KMDA outperforms 91.36% of its industry peers.
  • KMDA's Return On Invested Capital of 6.66% is amongst the best of the industry. KMDA outperforms 92.51% of its industry peers.
  • KMDA had an Average Return On Invested Capital over the past 3 years of 2.98%. This is significantly below the industry average of 18.14%.
  • The last Return On Invested Capital (6.66%) for KMDA is above the 3 year average (2.98%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.42%
ROE 7.71%
ROIC 6.66%
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
KMDA Yearly ROA, ROE, ROICKMDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

1.3 Margins

  • With an excellent Profit Margin value of 11.70%, KMDA belongs to the best of the industry, outperforming 91.36% of the companies in the same industry.
  • In the last couple of years the Profit Margin of KMDA has declined.
  • Looking at the Operating Margin, with a value of 15.88%, KMDA belongs to the top of the industry, outperforming 93.28% of the companies in the same industry.
  • KMDA's Operating Margin has declined in the last couple of years.
  • KMDA has a Gross Margin of 43.75%. This is in the better half of the industry: KMDA outperforms 74.66% of its industry peers.
  • In the last couple of years the Gross Margin of KMDA has grown nicely.
Industry RankSector Rank
OM 15.88%
PM (TTM) 11.7%
GM 43.75%
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
KMDA Yearly Profit, Operating, Gross MarginsKMDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • KMDA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, KMDA has about the same amount of shares outstanding.
  • Compared to 5 years ago, KMDA has more shares outstanding
  • The debt/assets ratio for KMDA is higher compared to a year ago.
KMDA Yearly Shares OutstandingKMDA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
KMDA Yearly Total Debt VS Total AssetsKMDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • KMDA has an Altman-Z score of 3.87. This indicates that KMDA is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.87, KMDA is in the better half of the industry, outperforming 69.48% of the companies in the same industry.
  • KMDA has a debt to FCF ratio of 0.61. This is a very positive value and a sign of high solvency as it would only need 0.61 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.61, KMDA belongs to the top of the industry, outperforming 94.63% of the companies in the same industry.
  • A Debt/Equity ratio of 0.04 indicates that KMDA is not too dependend on debt financing.
  • KMDA has a Debt to Equity ratio (0.04) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.61
Altman-Z 3.87
ROIC/WACC0.78
WACC8.51%
KMDA Yearly LT Debt VS Equity VS FCFKMDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • KMDA has a Current Ratio of 4.03. This indicates that KMDA is financially healthy and has no problem in meeting its short term obligations.
  • KMDA has a Current ratio of 4.03. This is comparable to the rest of the industry: KMDA outperforms 47.98% of its industry peers.
  • KMDA has a Quick Ratio of 2.24. This indicates that KMDA is financially healthy and has no problem in meeting its short term obligations.
  • With a Quick ratio value of 2.24, KMDA is not doing good in the industry: 71.40% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 4.03
Quick Ratio 2.24
KMDA Yearly Current Assets VS Current LiabilitesKMDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • KMDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.57%, which is quite impressive.
  • Measured over the past years, KMDA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.60% on average per year.
  • The Revenue has grown by 10.36% in the past year. This is quite good.
  • The Revenue has been growing slightly by 4.82% on average over the past years.
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%

3.2 Future

  • The Earnings Per Share is expected to grow by 31.28% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 10.57% on average over the next years. This is quite good.
EPS Next Y44.17%
EPS Next 2Y35.79%
EPS Next 3Y31.28%
EPS Next 5YN/A
Revenue Next Year12.37%
Revenue Next 2Y11.88%
Revenue Next 3Y10.57%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
KMDA Yearly Revenue VS EstimatesKMDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
KMDA Yearly EPS VS EstimatesKMDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 24.44 indicates a rather expensive valuation of KMDA.
  • Based on the Price/Earnings ratio, KMDA is valued cheaply inside the industry as 92.90% of the companies are valued more expensively.
  • KMDA's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.11.
  • A Price/Forward Earnings ratio of 18.36 indicates a rather expensive valuation of KMDA.
  • Based on the Price/Forward Earnings ratio, KMDA is valued cheaply inside the industry as 93.86% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of KMDA to the average of the S&P500 Index (28.13), we can say KMDA is valued slightly cheaper.
Industry RankSector Rank
PE 24.44
Fwd PE 18.36
KMDA Price Earnings VS Forward Price EarningsKMDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of KMDA indicates a rather cheap valuation: KMDA is cheaper than 96.93% of the companies listed in the same industry.
  • KMDA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. KMDA is cheaper than 94.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 27.18
EV/EBITDA 10.5
KMDA Per share dataKMDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of KMDA may justify a higher PE ratio.
  • KMDA's earnings are expected to grow with 31.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.55
PEG (5Y)N/A
EPS Next 2Y35.79%
EPS Next 3Y31.28%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • KMDA has a Yearly Dividend Yield of 2.35%.
  • KMDA's Dividend Yield is rather good when compared to the industry average which is at 1.17. KMDA pays more dividend than 98.66% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, KMDA pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.35%

5.2 History

  • KMDA is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
KMDA Yearly Dividends per shareKMDA Yearly Dividends per shareYearly Dividends per share 2025 0.05 0.1 0.15

5.3 Sustainability

DPN/A
EPS Next 2Y35.79%
EPS Next 3Y31.28%
KMDA Yearly Income VS Free CF VS DividendKMDA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

More info and screens

Find the best dividend stocksShow peers with best dividend

KAMADA LTD

NASDAQ:KMDA (2/27/2026, 10:43:06 AM)

8.8

-0.11 (-1.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-10
Earnings (Next)03-03
Inst Owners11.42%
Inst Owner Change-10.37%
Ins Owners2.34%
Ins Owner ChangeN/A
Market Cap507.58M
Revenue(TTM)174.79M
Net Income(TTM)20.45M
Analysts84.44
Price Target13.26 (50.68%)
Short Float %0.25%
Short Ratio0.9
Dividend
Industry RankSector Rank
Dividend Yield 2.35%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)20.52%
Min EPS beat(2)-4.61%
Max EPS beat(2)45.66%
EPS beat(4)3
Avg EPS beat(4)17.85%
Min EPS beat(4)-4.61%
Max EPS beat(4)45.66%
EPS beat(8)6
Avg EPS beat(8)19.32%
EPS beat(12)9
Avg EPS beat(12)7.95%
EPS beat(16)10
Avg EPS beat(16)-82.64%
Revenue beat(2)1
Avg Revenue beat(2)-0.44%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)0.61%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)2.19%
Revenue beat(8)3
Avg Revenue beat(8)-0.6%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)6
Avg Revenue beat(16)1.07%
PT rev (1m)0%
PT rev (3m)-11.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-18.42%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.92%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.27%
Valuation
Industry RankSector Rank
PE 24.44
Fwd PE 18.36
P/S 2.9
P/FCF 27.18
P/OCF 17.55
P/B 1.91
P/tB 2.16
EV/EBITDA 10.5
EPS(TTM)0.36
EY4.09%
EPS(NY)0.48
Fwd EY5.45%
FCF(TTM)0.32
FCFY3.68%
OCF(TTM)0.5
OCFY5.7%
SpS3.03
BVpS4.6
TBVpS4.07
PEG (NY)0.55
PEG (5Y)N/A
Graham Number6.1
Profitability
Industry RankSector Rank
ROA 5.42%
ROE 7.71%
ROCE 8.43%
ROIC 6.66%
ROICexc 8.52%
ROICexgc 9.66%
OM 15.88%
PM (TTM) 11.7%
GM 43.75%
FCFM 10.68%
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.78%
ROICexc(5y)N/A
ROICexgc(3y)8.93%
ROICexgc(5y)N/A
ROCE(3y)3.78%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-12.12%
ROICexc growth 3YN/A
ROICexc growth 5Y-24.72%
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
F-Score7
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.61
Debt/EBITDA 0.22
Cap/Depr 66.53%
Cap/Sales 5.86%
Interest Coverage 35.82
Cash Conversion 67%
Profit Quality 91.33%
Current Ratio 4.03
Quick Ratio 2.24
Altman-Z 3.87
F-Score7
WACC8.51%
ROIC/WACC0.78
Cap/Depr(3y)51.63%
Cap/Depr(5y)66.68%
Cap/Sales(3y)4.57%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
EPS Next Y44.17%
EPS Next 2Y35.79%
EPS Next 3Y31.28%
EPS Next 5YN/A
Revenue 1Y (TTM)10.36%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%
Revenue Next Year12.37%
Revenue Next 2Y11.88%
Revenue Next 3Y10.57%
Revenue Next 5YN/A
EBIT growth 1Y56.45%
EBIT growth 3YN/A
EBIT growth 5Y-2.54%
EBIT Next Year134.37%
EBIT Next 3Y44.92%
EBIT Next 5YN/A
FCF growth 1Y937.39%
FCF growth 3YN/A
FCF growth 5Y7.84%
OCF growth 1Y334.95%
OCF growth 3YN/A
OCF growth 5Y11.54%

KAMADA LTD / KMDA FAQ

Can you provide the ChartMill fundamental rating for KAMADA LTD?

ChartMill assigns a fundamental rating of 6 / 10 to KMDA.


What is the valuation status for KMDA stock?

ChartMill assigns a valuation rating of 7 / 10 to KAMADA LTD (KMDA). This can be considered as Undervalued.


Can you provide the profitability details for KAMADA LTD?

KAMADA LTD (KMDA) has a profitability rating of 7 / 10.


How financially healthy is KAMADA LTD?

The financial health rating of KAMADA LTD (KMDA) is 6 / 10.